Literature DB >> 18632695

Generation of isogenic pluripotent stem cells.

James A Byrne1.   

Abstract

The ability to reprogram somatic cell nuclei back into a pluripotent epigenetic state provides exciting new possibilities for in vitro research and cell transplantation therapy. There has been a significant quantity of recent research studies demonstrating that this epigenetic reprogramming process is possible with human and non-human primate somatic cells. In this review, various methodologies for reprogramming primate somatic cells into pluripotent stem cells are examined, epigenetic reprogramming following somatic cell nuclear transfer and normal primate embryonic development is compared, and future potential methods to induce direct reprogramming without using genetic modification are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18632695     DOI: 10.1093/hmg/ddn053

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  12 in total

Review 1.  Immunogenicity and allogenicity: a challenge of stem cell therapy.

Authors:  Dominique Charron; Caroline Suberbielle-Boissel; Reem Al-Daccak
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

2.  Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.

Authors:  Jeremy I Pearl; Andrew S Lee; Dennis B Leveson-Gower; Ning Sun; Zhumur Ghosh; Feng Lan; Julia Ransohoff; Robert S Negrin; Mark M Davis; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

3.  Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.

Authors:  Jason P Awe; Eric H Gschweng; Agustin Vega-Crespo; Jon Voutila; Mary H Williamson; Brian Truong; Donald B Kohn; Noriyuki Kasahara; James A Byrne
Journal:  Stem Cells Transl Med       Date:  2015-01-09       Impact factor: 6.940

4.  Regenerative medicine strategies for treatment of neurogenic bladder.

Authors:  Roberto Soler; Claudius Fullhase; Anthony Atala
Journal:  Therapy       Date:  2009

5.  Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame.

Authors:  Lijian Shao; Wei Feng; Yan Sun; Hao Bai; Jun Liu; Caroline Currie; Jaejung Kim; Rafael Gama; Zack Wang; Zhijian Qian; Lucy Liaw; Wen-Shu Wu
Journal:  Cell Res       Date:  2009-03       Impact factor: 25.617

Review 6.  Stem cells in the nervous system.

Authors:  Angel R Maldonado-Soto; Derek H Oakley; Hynek Wichterle; Joel Stein; Fiona K Doetsch; Christopher E Henderson
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

Review 7.  Gene-delivery systems for iPS cell generation.

Authors:  Lijian Shao; Wen-Shu Wu
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

Review 8.  Modeling neurodevelopmental disorders using human pluripotent stem cells.

Authors:  Michael Telias; Dalit Ben-Yosef
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

Review 9.  Small molecules and stem cells. Potency and lineage commitment: the new quest for the fountain of youth.

Authors:  Agnès I Lukaszewicz; Michael K McMillan; Michael Kahn
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

10.  Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts.

Authors:  James A Byrne; Ha Nam Nguyen; Renee A Reijo Pera
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.